ProCE Banner Activity

CME

Management of Initial and Recurrent C. difficile Infections

Multimedia
Gain expert insights on the latest data and guidance for managing challenging C. difficile infections in this case-focused, CME-certified Interactive Virtual Presentation.

Physicians : maximum of 0.75 AMA PRA Category 1 {Credit}

Released: November 21, 2018

Expiration: November 24, 2019

No longer available for credit.

Share

Faculty

Ciarán P. Kelly

Ciarán P. Kelly, MD

Professor of Medicine
Department of Medicine
Harvard Medical School
Attending Physician
Division of Gastroenterology
Department of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

Supported by an educational grant from

Merck Human Health HIV

Target Audience

This program is intended for physicians and other healthcare providers who care for patients with Clostridium difficile infection.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Describe serologic and fecal tests for detection of toxigenic C difficile and their indications for use
  • List recommended antimicrobial regimens that have the highest levels of efficacy in treating primary CDI
  • Describe recent advances in the prevention of recurrent CDI in high risk patients and their place in therapy

Disclosure

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty Disclosure

Primary Author

Ciarán P. Kelly, MD

Professor of Medicine
Department of Medicine
Harvard Medical School
Attending Physician
Division of Gastroenterology
Department of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Ciarán P. Kelly, MD, has disclosed that he has received consulting fees from Artugen, Merck, and Vedanta, fees for non-CME/CE services from Biocodex, and funds for research support from Institut Merieux.

Staff Disclosure

Staff

Ashley Bohn, PhD, MS, RVT

Clinical Editor

Ashley Bohn, PhD, has disclosed that she has received fees for non-CME activities from Merck and Eli Lilly.

Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no significant financial relationships to disclose.

Jenny Schulz, PhD

Associate Managing Editor, Hepatitis
Clinical Care Options, LLC

Jenny Schulz, PhD, has no significant financial relationships to disclose.

Ryan P. Topping, PhD

Associate Managing Editor

Ryan Topping, PhD, has no significant financial relationships to disclose.

Instructions for Credit

Joint Accreditation Statement

In support of improving patient care, Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The PIM planners and managers have nothing to disclose.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Additional Information

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 21, 2018, through November 24, 2019:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve participants’ clinical competence in managing patients with Clostridium difficile infection.